German company Biontech and the American Concern Pfizer Following the manufacturers of Moderna and Astrazeneca reported the beginning of the clinical trials of the vaccine on children, reports Deutsche Vell.
“together with our partner Biontech we introduced a vaccine of the first group of healthy children within the framework of the ongoing global phase of clinical trials,” said the representative of Pfizer.
As part of the study, it is supposed to examine the safety, tolerance and efficiency of the vaccine in the age rules from six months to 11 years. According to plan, Biontech / Pfizer will be applied to children from the beginning of 2022.